Pharma Times

JULY 26, 2023

The new company’s core mission is to boost patient access to disease-modifying treatments - News - PharmaTimes

99

99

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. While bear markets and financial volatility are not new in biotech, rising interest rates, growing inflation, and the war in Ukraine have all fueled uncertainty in recent times.

Marketing 324

Marketing Gene Therapy Manufacturing Pharma Companies 324

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. While bear markets and financial volatility are not new in biotech, rising interest rates, growing inflation, and the war in Ukraine have all fueled uncertainty in recent times.

Marketing 162

Marketing Gene Therapy Manufacturing Pharma Companies 162

World of DTC Marketing

NOVEMBER 10, 2020

SUMMARY : Pfizer’s 90 percent effectiveness is very impressive, but the rate is based on a relatively small number of people and the data has not been peer-reviewed but today headlines rule the news, not content. Pfizer’s results are promising and are coming at a time when the world is anxiously awaiting positive news.

Vaccination 286

Vaccination Vaccine Marketing Drugs 286

World of DTC Marketing

FEBRUARY 7, 2022

What has/is happening at Biogen is a train wreck, and the only way to correct this disaster is to tear it down and rebuild the company from the top down. At 99% of pharma companies, that's a huge no-no. At 99% of pharma companies, that’s a huge no-no. Even if they market a new drug with good data, will HCPs listen?

Pharma Companies 253

Pharma Companies Marketing Sales Clinical Trials 253

World of DTC Marketing

NOVEMBER 24, 2021

From 2009 to 2019, the median monthly treatment costs for new drugs at launch reached $11,755 in the U.S… According to an analysis published by JAMA Oncology, prices for new drugs approved for use in the treatment of cancer in the United States more than doubled over the past decade. SUMMARY: The U.S. Click to Tweet.

Drugs 266

Drugs FDA Approval Research Medicine 266

Pharma Mirror

OCTOBER 30, 2020

Leading cloud temperature management solutions provider, TSS Middle East, today announces the appointment of Christopher Hobeiche as the new regional manager for their Middle East operations. TSS provides temperature monitoring solutions.

Manufacturing 130

Manufacturing 130

STAT News

APRIL 10, 2023

UnitedHealth Group has acquired Crystal Run Healthcare, a prominent physician group in New York. Neither company issued a press release. The deal only came to light from an email obtained by the Mid-Hudson News. There was no fanfare. Continue to STAT+ to read the full story…

Nurses 98

Nurses Doctors Doctor 98

STAT News

MARCH 17, 2023

last Friday, Ketamine Wellness Centers CEO Kevin Nicholson sent an email: In 30 minutes, the company would no longer be in business, he said. It was an abrupt end to what Nicholson depicted just months earlier as a booming business with plans for new clinics and treatments. To patients, the news came as a complete shock.

124

124

STAT News

NOVEMBER 8, 2022

Following a year of executive shakeups and business rejiggering, Talkspace’s third-quarter earnings came with some good news: The company finally appointed a new CEO and key numbers continue to point in the right direction.

98

98

World of DTC Marketing

SEPTEMBER 7, 2022

Wall Street wants growth, as do investors, but that may be impossible for pharmaceutical companies. In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. Biogen’s failure should be a warning to other pharma companies. ” The U.S.

Pharma Companies 210

Pharma Companies Marketing Drugs Production 210

World of DTC Marketing

AUGUST 9, 2021

86% of diagnostic device companies, 65% of pharma marketers, and over half of biotechs use social as a critical part of their marketing mix to reach HCPs. Most HCPs go to Medscape as a “first stop” in the morning to get their healthcare news. The HCP team came away from the chat with new issues that needed to be addressed.

Nurses 294

Nurses Marketing Pharma Companies Production 294

Pharmaceutical Technology

JUNE 7, 2023

The company now plans to combine it with its pipeline reversal blocking agent. Shares in the US-based company previously surged after the topline data reveal in April. All three agents are licensed from Cornell University, New York. BX1000 is an intermediate duration, clinical-stage blocking agent.

Clinical Trials 130

Clinical Trials Clinical Trials Licensing Licensing 130

World of DTC Marketing

FEBRUARY 1, 2022

According to STAT News “after a double-digit decline in 2021, the sector has fallen another 20% in the new year, erasing billions in value and leading even the most seasoned investors to question whether biotech has further to fall. Can small biotech companies survive? What’s scaring investors? 2wo: Crowded markets.

Drugs 234

Drugs Development Marketing Vaccination 234

Pharmaceutical Technology

DECEMBER 27, 2022

Our response to the worldwide pandemic evolved over time, and so did the needs of the sector and the people relying on healthcare companies to deliver solutions. Along the way, mergers and acquisitions continued to happen, new drugs and devices got approved, and innovations in the clinical trial industry were introduced.

Clinical Trials 306

Clinical Trials Clinical Trials Trials Vaccination 306

World of DTC Marketing

NOVEMBER 24, 2020

SUMMARY : In a 2019 Pew Research Center poll, more Americans said they consider made-up news a bigger problem than terrorism, illegal immigration, racism, and sexism. Pharma companies have a major opportunity to earn back the trust of a skeptical public but it’s going to take a consistent effort.

Scientist 277

Scientist Pharma Companies Production Sales 277

Drug Discovery World

FEBRUARY 16, 2024

News round-up for 12-16 February by DDW Digital Content Editor Diana Spencer. This week our news highlights focus on skin conditions, with positive updates on hidradenitis suppurativa, systemic sclerosis, wound-healing, and other dermatological conditions like atopic dermatitis and vitiligo.

Dermatology 52

Dermatology Drugs Gene Expression Antibody 52

World of DTC Marketing

DECEMBER 10, 2021

Right now, I could make a great argument that Biogen’s character is trashed and that they are a company in dire need of authentic leadership. The company could lay off as many as 1,000 employees as it deals with the controversial treatment. The company was riding high on their MS drugs, but the competition was on the way.

Drugs 231

Drugs Marketing Development 231

Pharmaceutical Technology

MAY 12, 2023

Matinas announced the news in a May 10 statement. The news means the collaboration between the two companies lasted just over a year. However, the technology still shows signs of promise, the company says pointing to other studies it conducted with related mRNA formulations.

Vaccination 130

Vaccination Vaccine In-Vivo In-Vitro 130

Outsourcing Pharma

SEPTEMBER 1, 2022

This monthâs announcements of appointments, acquisitions, new hires, and other news include Standigm, Astellas Pharma, Trialbee, and other key companies.

Regulation 52

Regulation Marketing 52

World of DTC Marketing

NOVEMBER 11, 2020

The top 50 articles garnered more than 12 million shares, comments, and reactions this year, mostly on Facebook” Despite the rise in online health seekers, pharma is not part of the solution to combat fake health news. With a new administration due to take charge my feeling is that social media’s day of reckoning is soon coming.

Marketing 195

Marketing Pharma Companies Sales Drugs 195

World of DTC Marketing

JULY 15, 2021

SUMMARY: The Committee on Oversight and Reform and the Committee on Energy and Commerce is investigating the approval process for Biogen’s new Alzheimer’s drug. Janet Woodcock acknowledged on Wednesday her agency may have misstepped in the handling of its polarizing approval of a new Alzheimer’s drug.

Pharma Companies 202

Pharma Companies Drugs Development Production 202

Drug Discovery World

APRIL 5, 2024

News round-up for 1-5 April by DDW Digital Content Editor Diana Spencer. R&D partnership to jointly develop new ALS drugs PrecisionLife and the Nucleic Acid Therapy Accelerator (NATA) have announced a collaboration to co-develop novel oligonucleotide therapies for sporadic motor neurone disease/ALS.

Drugs 52

Drugs Life Science Development Research 52

Outsourcing Pharma

SEPTEMBER 2, 2021

This monthâs news on new hires, board launches, acquisitions, and other important news includes items on Pfizer, Javara, Clinical Ink, and other companies.

Regulation 52

Regulation Marketing 52

Drug Discovery World

AUGUST 12, 2022

News round-up by DDW’s Reece Armstrong for 8-12 August . New insights into melanoma, a company transition into life sciences and a Lyme disease vaccine are some of the stories in this week’s news round-up. Life sciences company PerkinElmer will divest its?Applied, billion. . billion. .

Life Science 52

Life Science Drugs Vaccination Vaccine 52

STAT News

JULY 12, 2022

Somewhere in New Zealand, the first patient ever has been dosed with a kind of gene-editing treatment known as a base editor, a newer way of utilizing CRISPR for gene editing. The company studying the treatment, Verve Therapeutics, announced the news Tuesday.

Gene Editing 98

Gene Editing Gene Therapy Gene Cardiology 98

Outsourcing Pharma

SEPTEMBER 16, 2021

This monthâs roundup of new technology, equipment, and industry partnerships includes news from IBM, IQVIA, Mediata, Labcorp, and other notable companies.

Regulation 59

Regulation Marketing 59

Pharmaceutical Technology

MAY 16, 2023

This news was announced during the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting in Los Angeles. In the next 12 months, the organisation will conduct the work leading up to investigational new drug (IND) submissions for new gene therapies.

Gene Therapy 227

Gene Therapy Gene Research Clinical Trials 227

Pharmaceutical Technology

AUGUST 16, 2022

Even giant pharma companies with large internal production capabilities are leaning on outsourcing to meet market demand for huge numbers of injectables, including high-value biologics and Covid-19 vaccines, according to a GlobalData analysis.

Gene Therapy 162

Gene Therapy Packaging Packaging Contract Packaging 162

World of DTC Marketing

JANUARY 24, 2022

Most small biotech companies rely on venture capitalist funding to develop new drugs but is that a good way to go? The amount of money required to gain approval of a new drug has been hotly debated, but it also costs a hell of a lot of money to launch a drug in today’s market. not necessarily. Only about $2.2

Life Science 225

Life Science Drugs Genetic Disease Development 225

XTalks

MAY 3, 2024

Healthcare company Real Chemistry announced its introduction of IRIS, an insights-as-a-service platform that will deliver all things related to GLP-1 drugs. This includes news on the obesity market, the latest info on current and future GLP-1 drugs and the overall growing influence of GLP-1 therapies.

Drugs 52

Drugs Clinical Trials Clinical Trials Marketing 52

Pharmaceutical Technology

DECEMBER 28, 2022

Certain operational obligations of the companies that are related to GS-1811 have also been terminated as part of the transaction. Now, the company will be solely responsible for all further research, development, and commercialisation of GS-1811 across the world.

Licensing 130

Licensing Licensing Clinical Trials Clinical Trials 130

Drug Discovery World

AUGUST 8, 2023

The second quarter of 2023 has seen steady growth in financing activity for the UK’s life sciences sector, according to new data released by the BioIndustry Association (BIA) and Clarivate. The positive news comes soon after industry figures welcomed recent announcements to unlock new sources of capital in the City of London.

Life Science 98

Life Science Marketing Drugs 98

World of DTC Marketing

MAY 14, 2021

One change in the workplace is that employees want more of a say about their company when it comes to social and moral issues. The company employs around 60 people, and roughly a third of the company appears to have accepted buyouts to leave, many citing new company policies. The media loves negative news.

Drugs 194

Drugs Production Marketing Development 194

Drug Discovery World

AUGUST 19, 2022

News round-up by DDW Editor Reece Armstrong for 15-19 August. Covid booster approvals, positive results for Malaria vaccines and new CEOs are some of the stories in this week’s news round-up. . Artificial intelligence (AI) company Atomwise has signed an exclusive research collaboration with Sanofi to use its AtomNet?platform

Drugs 52

Drugs Vaccination Vaccine Medicine 52

Drug Discovery World

JUNE 2, 2023

News round-up for 29 May – 2 June by DDW Digital Content Editor Diana Spencer. With National Cancer Research Month coming to an end and the American Society of Clinical Oncology Annual Meeting currently taking place in Chicago (2-6 June), it’s been another busy week for cancer drug development news.

Drugs 52

Drugs HR Antibody Clinical Trials 52

Pharmaceutical Technology

MAY 16, 2023

The company is also in line to receive an additional $110m in future milestone payments, depending on the Chikungunya vaccine development and sales performance of the two marketed vaccines. The news comes after a tricky opening quarter for Emergent. Emergent says most employees working at these facilities will join Bavarian Nordic.

Vaccination 130

Vaccination Vaccine Licensing Licensing 130